Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4u95 | MIY | Multidrug efflux pump subunit AcrB |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4u95 | MIY | Multidrug efflux pump subunit AcrB | / | 1.000 | |
| 4dbw | 511 | Aldo-keto reductase family 1 member C3 | / | 0.478 | |
| 1x1a | SAM | C-20 methyltransferase | / | 0.466 | |
| 1t7o | 152 | Carnitine O-acetyltransferase | 2.3.1.7 | 0.457 | |
| 2fm5 | M99 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.455 | |
| 4e0u | 0MV | Cyclic dipeptide N-prenyltransferase | / | 0.452 | |
| 2f38 | 15M | Aldo-keto reductase family 1 member C3 | / | 0.450 | |
| 2v0m | KLN | Cytochrome P450 3A4 | / | 0.450 | |
| 1ry0 | PG2 | Aldo-keto reductase family 1 member C3 | / | 0.448 | |
| 1y60 | H4M | 5,6,7,8-tetrahydromethanopterin hydro-lyase | 4.2.1.147 | 0.447 | |
| 4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.447 | |
| 4ajf | F03 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.446 | |
| 4pnm | NU1 | Tankyrase-2 | 2.4.2.30 | 0.445 | |
| 1soj | IBM | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.443 | |
| 1y2b | DEE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.443 | |
| 2wd8 | VGF | Pteridine reductase | / | 0.443 | |
| 2g7y | MO9 | Cathepsin S | 3.4.22.27 | 0.442 | |
| 3wav | DWV | Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | 3.1.4.39 | 0.442 | |
| 1xds | DRA | Aclacinomycin 10-hydroxylase RdmB | 4.1.1 | 0.441 | |
| 2g26 | 3LG | Renin | 3.4.23.15 | 0.441 | |
| 4bft | ZVT | Pantothenate kinase | 2.7.1.33 | 0.441 |